{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:35:39Z","timestamp":1780374939662,"version":"3.54.1"},"reference-count":35,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.3201\/eid3206.251399","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:07:55Z","timestamp":1779289675000},"source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial-Resistant\n                    <i>Neisseria gonorrhoeae<\/i>\n                    of Public Health Concern, New South Wales, Australia, 2022\u20132024"],"prefix":"10.3201","volume":"32","author":[{"given":"Liz J.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J.","family":"Van Hal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Lahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janaki","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3206.251399-202605201105-R1","unstructured":"Australian STI Management Guidelines. Gonorrhoea. 2024 [cited 2025 Dec 3]. https:\/\/sti.guidelines.org.au\/sexually-transmissible-infections\/gonorrhoea"},{"key":"key-10.3201\/eid3206.251399-202605201105-R2","unstructured":"Centers for Disease Control and Prevention. Gonococcal Isolate Surveillance Project (GISP) profiles [cited 2025 Dec 3]. https:\/\/www.cdc.gov\/sti-statistics\/gisp-profiles"},{"key":"key-10.3201\/eid3206.251399-202605201105-R3","unstructured":"European Centre for Disease Prevention and Control. Gonococcal antimicrobial susceptibility surveillance in the EU\/EEA [cited 2025 Dec 3]. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/gonococcal-antimicrobial-susceptibility-surveillance-europe.pdf"},{"key":"key-10.3201\/eid3206.251399-202605201105-R4","unstructured":"Public Health Agency of Canada. Dashboard on the Enhanced Surveillance of Antimicrobial-resistant Gonorrhea system (ESAG): 2018 to 2023 [cited 2025 Dec 3]. https:\/\/health-infobase.canada.ca\/esag"},{"key":"key-10.3201\/eid3206.251399-202605201105-R5","unstructured":"Sun S, Narayanan P, Vickers A, Pitt R, Doumith MX, David S,  GRASP report: data to August 2024 [cited 2025 Dec 3]. https:\/\/www.gov.uk\/government\/publications\/gonococcal-resistance-to-antimicrobials-surveillance-programme-grasp-report\/grasp-report-data-to-august-2024"},{"key":"key-10.3201\/eid3206.251399-202605201105-R6","unstructured":"World Health Organization. Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): surveillance report 2023. 2024 [cited 2025 Dec 3]. https:\/\/iris.who.int\/bitstream\/handle\/10665\/379546\/9789240102927-eng.pdf"},{"key":"key-10.3201\/eid3206.251399-202605201105-R7","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2025.49.056","article-title":"Australian Gonococcal Surveillance Programme annual report, 2024.","volume":"49","author":"Lahra","year":"2025","journal-title":"Commun Dis Intell"},{"key":"key-10.3201\/eid3206.251399-202605201105-R8","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 36th edition. Supplement M100. Wayne (PA): The Institute; 2026."},{"key":"key-10.3201\/eid3206.251399-202605201105-R9","unstructured":"Health NSW. Antimicrobial resistant gonococcal infections of public health significance. Appendix D: standard operating procedure. 2025 [cited 2025 Dec 3]. www.health.nsw.gov.au\/Infectious\/controlguideline\/Documents\/gonorrhoea-appendix-d-sop-amr.pdf"},{"key":"key-10.3201\/eid3206.251399-202605201105-R10","unstructured":"Health Protection NSW. Gonococcal notification form for antimicrobial infections of public health significance 2022 [cited 2025 Dec 3]. www.health.nsw.gov.au\/Infectious\/controlguideline\/Documents\/gonococcal-notification-form-fillable.pdf"},{"key":"key-10.3201\/eid3206.251399-202605201105-R11","unstructured":"World Health Organization. Countries. 2025 [cited 2025 Dec 3]. https:\/\/www.who.int\/countries"},{"key":"key-10.3201\/eid3206.251399-202605201105-R12","doi-asserted-by":"publisher","first-page":"e547","DOI":"10.1016\/S1473-3099(24)00486-9","article-title":"Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone.","volume":"24","author":"van Hal","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R13","unstructured":"National Health and Medical Research Council. Ethical considerations in quality assurance and evaluation activities 2024 [cited 2025 Dec 3]. https:\/\/www.nhmrc.gov.au\/about-us\/publications\/ethical-considerations-quality-assurance-and-evaluation-activities"},{"key":"key-10.3201\/eid3206.251399-202605201105-R14","unstructured":"Ogilvie E, McManus H, Callander D, Guy R, Basheer E, Sullivan E,  The Third Australian Study of Health and Relationships: report to the NSW Ministry of Health. 2025 [cited 2025 Dec 3]. https:\/\/unsworks.unsw.edu.au\/entities\/publication\/642dd75a-1e94-4032-ad49-765ed5fe7850"},{"key":"key-10.3201\/eid3206.251399-202605201105-R15","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1038\/s41467-024-52343-0","article-title":"Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia.","volume":"15","author":"Taouk","year":"2024","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid3206.251399-202605201105-R16","unstructured":"MacGibbon J, Chan C, Bavinton B, Mao L, Smith AK, Molyneux A,  GBQ+ Community Periodic Survey: Sydney 2024 [cited 2025 Dec 3]. 10.26190\/unsworks\/30413"},{"key":"key-10.3201\/eid3206.251399-202605201105-R17","doi-asserted-by":"publisher","first-page":"e2030806","DOI":"10.1001\/jamanetworkopen.2020.30806","article-title":"Comparison of trends in rates of sexually transmitted infections before vs after initiation of HIV preexposure prophylaxis among men who have sex with men.","volume":"3","author":"McManus","year":"2020","journal-title":"JAMA Netw Open"},{"key":"key-10.3201\/eid3206.251399-202605201105-R18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5694\/mja2.52258","article-title":"Australian consensus statement on doxycycline post-exposure prophylaxis (doxy-PEP) for the prevention of syphilis, chlamydia and gonorrhoea among gay, bisexual and other men who have sex with men.","volume":"220","author":"Cornelisse","year":"2024","journal-title":"Med J Aust"},{"key":"key-10.3201\/eid3206.251399-202605201105-R19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.33321\/cdi.2023.47.45","article-title":"Australian Gonococcal Surveillance Programme annual report, 2022.","volume":"47","author":"Lahra","year":"2023","journal-title":"Commun Dis Intell"},{"key":"key-10.3201\/eid3206.251399-202605201105-R20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.33321\/cdi.2025.49.007","article-title":"Australian Gonococcal Surveillance Programme annual report, 2023.","volume":"49","author":"Lahra","year":"2025","journal-title":"Commun Dis Intell"},{"key":"key-10.3201\/eid3206.251399-202605201105-R21","unstructured":"Broady T, Chan C, MacGibbon J, Smith AK, Mao L, Tremain D,  GBQ+ Community Periodic Survey: Sydney 2025 [cited 2025 Dec 3]. 10.26190\/unsworks\/31367"},{"key":"key-10.3201\/eid3206.251399-202605201105-R22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/OLQ.0000000000001810","article-title":"Doxycycline postexposure prophylaxis could induce cross-resistance to other classes of antimicrobials in Neisseria gonorrhoeae: an in silico analysis.","volume":"50","author":"Vanbaelen","year":"2023","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R23","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S1473-3099(23)00479-6","article-title":"The Enhanced Gonococcal Surveillance Programme, Cambodia.","volume":"23","author":"Ouk","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R24","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3201\/eid3007.240354","article-title":"World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023.","volume":"30","author":"Ouk","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R25","doi-asserted-by":"crossref","unstructured":"Lan PT, Nguyen HT, Golparian D, Thuy Van NT, Maatouk I, Unemo M,  The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023. Lancet Reg Health West Pac. 2024;48:101125. rn>10.1016\/j.lanwpc.2024.101125","DOI":"10.1016\/j.lanwpc.2024.101125"},{"key":"key-10.3201\/eid3206.251399-202605201105-R26","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S1473-3099(24)00230-5","article-title":"Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam.","volume":"24","author":"Adamson","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/infdis\/jiad258","article-title":"Antimicrobial resistance profiling and genome analysis of the penA-60.001 Neisseria gonorrhoeae clinical isolates in China in 2021.","volume":"228","author":"Tang","year":"2023","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.15585\/mmwr.mm7312a2","article-title":"Ceftriaxone-resistant gonorrhea\u2014China, 2022.","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid3206.251399-202605201105-R29","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/jac\/dkae369","article-title":"Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015\u201324: an observational analysis.","volume":"79","author":"Fifer","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3206.251399-202605201105-R30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1473-3099(18)30122-1","article-title":"Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study.","volume":"18","author":"Fifer","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/jac\/dkaa536","article-title":"Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016\u201318.","volume":"76","author":"Salmer\u00f3n","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid3206.251399-202605201105-R32","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/cid\/ciab132","article-title":"Sustained transmission of Neisseria gonorrhoeae with high-level resistance to azithromycin, in Indianapolis, Indiana, 2017\u20132018.","volume":"73","author":"Holderman","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R33","doi-asserted-by":"publisher","first-page":"e0097023","DOI":"10.1128\/spectrum.00970-23","article-title":"Sustained transmission of Neisseria gonorrhoeae strains with high-level azithromycin resistance (MIC > 256 \u03bcg\/mL) in Argentina, 2018 to 2022.","volume":"11","author":"Gianecini","year":"2023","journal-title":"Microbiol Spectr"},{"key":"key-10.3201\/eid3206.251399-202605201105-R34","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/OLQ.0000000000001060","article-title":"Increase in gonorrhea incidence associated with enhanced partner notification strategy.","volume":"46","author":"Schleihauf","year":"2019","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid3206.251399-202605201105-R35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12941-023-00576-0","article-title":"Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections.","volume":"22","author":"Brendefur Corwin","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:08:01Z","timestamp":1779289681000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/32\/6\/25-1399_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3206.251399","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}